首页|瑞香素调节Shh/Gli1信号通路对乳腺癌增殖、凋亡和化疗敏感性的影响

瑞香素调节Shh/Gli1信号通路对乳腺癌增殖、凋亡和化疗敏感性的影响

扫码查看
目的 探究瑞香素调节音猬因子(Shh)/胶质细胞瘤转录因子 1(Gli1)信号通路对乳腺癌增殖、凋亡和化疗敏感性的影响.方法 将人乳腺癌细胞株 MDA-MB-231 细胞分为对照组、瑞香素组(40 μmol/L 瑞香素)、GANT61 组(10 μmol/L GANT61)、瑞香素+GANT61 组(40 μmol/L瑞香素和 10 μmol/L GANT61);CCK-8 实验检测MDA-MB-231 细胞增殖;划痕试验检测MDA-MB-231 细胞迁移情况;在上述各分组细胞中加入 1mg/L 阿霉素(Dox)处理 48h后CCK-8实验检测细胞化疗敏感性;流式细胞术检测MDA-MB-231 细胞凋亡情况;Western blot检测MDA-MB-231 细胞Shh/Gli1 通路及凋亡相关蛋白表达水平.结果 与 0 μmol/L比较,随着瑞香素的剂量增加MDA-MB-231 细胞存活率显著降低(P<0.05),而与 40 μmol/L比较,50 μmol/L瑞香素处理MDA-MB-231 细胞存活率无差异(P>0.05),因此选择 40 μmol/L瑞香素作为后续实验的干预条件;与对照组比较,瑞香素组和GANT61 组OD450 值、划痕愈合率以及Gli1、Bcl-2蛋白表达显著降低(P<0.05),Bax蛋白表达、细胞凋亡率和Dox化疗敏感性显著升高(P<0.05);与瑞香素组比较,瑞香素+GANT61 组OD450 值、划痕愈合率以及Gli1、Bcl-2蛋白表达显著降低(P<0.05),Bax蛋白表达、细胞凋亡率和Dox化疗敏感性显著升高(P<0.05).结论 瑞香素可能通过抑制Shh/Gli1 信号通路来抑制乳腺癌细胞增殖,诱导细胞凋亡以及提高化疗敏感性.
Effects of daphnetin on the proliferation,apoptosis and chemosensitivity of breast cancer by regulating the Shh/Gli1 signaling pathway
Objective To investigate the effects of daphnetin on the proliferation,apoptosis and chemosensitivity of breast cancer by regulating the sonic hedgehog(Shh)/glioma-associated oncogene homologue 1(GLI1)signaling pathway.Methods The human breast cancer cell line MDA-MB-231 was divided into control group(blank control),daphnetin group(40μmol/L daphnetin),glioma-associated oncogene(Gli)antagonist-61(GANT61)group(10μmol/L GANT61),and daphnetin+GANT61 group(40μmol/L daphnetin and 10μmol/L GANT61).Cell proliferation,and migration were assessed by CCK-8 assay and wound healing assay,respectively.After adding 1mg/L doxorubicin(Dox)in above cells for 48 hours,chemotherapy sensitivity and apoptosis were assessed by CCK-8 assay and flow cytometry,respectively.Protein expressions of key proteins in the Shh/Gli1 signaling pathway and apoptosis proteins were detected by Western blot.Results Compared with that of control group,the survival rate of MDA-MB-231 cells significantly decreased with the increasing concentration of daphnetin(P<0.05).There was no significant difference in the survival rate of MDA-MB-231 cells treated with 40μmol/L and 50μmol/L daphnetin(P>0.05).Therefore,40μmol/L daphnetin was chosen as the intervention condition for subsequent experiments.Compared with those of the control group,cells in the daphnetin group and GANT61 group presented significantly lower optical density at 450nm(OD450)value,scratch healing rate,and protein expressions of Gli1 and B cell lymphoma-2(Bcl-2)(P<0.05),and significantly higher protein expression of Bax,apoptotic rate,and chemotherapy sensitivity to Dox(P<0.05).Compared with those of the daphnetin group,cells in the daphnetin + GANT61 group presented significantly lower OD450 value,scratch healing rate,and protein expressions of Gli1 and Bcl-2(P<0.05),and significantly higher protein expression of Bax,apoptotic rate,and chemotherapy sensitivity to Dox(P<0.05).Conclusion Daphnetin may inhibit the proliferation of breast cancer cells,induce apoptosis and improve chemosensitivity by inhibiting the Shh/Gli1 signaling pathway.

daphnetinsonic hedgehogglioma associated oncogene homolog 1breast cancerproliferationapoptosischemotherapy sensitivity

赵琳、朱宏飞

展开 >

430070 湖北省武汉市第三医院药学部

湖北省中医院(湖北中医药大学附属医院)麻醉科

瑞香素 音猬因子 胶质细胞瘤转录因子1 乳腺癌 增殖 凋亡 化疗敏感性

湖北省中医药管理局中医药科研项目武汉市卫生和计划生育委员会科研项目

ZY2023F011WX18D06

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(4)
  • 21